Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1446]
News [2942]
Articles [129]
Editorials [5]
Conferences [154]
elearning [6]
mRCC: Real-world experience: achieving efficacy beyond clinical trials
Dr Nizar Tannir - University of Texas M.D. Anderson Cancer Center, Houston, USA
mRCC: Real-world experience: achieving efficacy beyond clinical trials ( Dr Nizar Tannir - University of Texas M.D. Anderson Cancer Center, Houston, USA )
11 Feb 2015
Optimizing survival in advanced prostate cancer: CHAARTED: What are the...
Prof Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA
Optimizing survival in advanced prostate cancer: CHAARTED: What are the implications for the future? ( Prof Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA )
29 Jan 2015
Optimizing Survival in Advanced Prostate Cancer: Conclusion
Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium
Optimizing Survival in Advanced Prostate Cancer: Conclusion ( Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium )
29 Jan 2015
Latest achievements in the p-medicine project
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
Latest achievements in the p-medicine project ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
19 Jan 2015
Global cancer and the importance of government engagement
Dr Chris Wild - Director of the International Agency for Research on Cancer
Global cancer and the importance of government engagement ( Dr Chris Wild - Director of the International Agency for Research on Cancer )
18 Dec 2014
Comment: Fulvestrant improves survival over anastrozole for patients with...
Prof Kent Osborne - Baylor College of Medicine, Houston, USA
Comment: Fulvestrant improves survival over anastrozole for patients with advanced breast cancer ( Prof Kent Osborne - Baylor College of Medicine, Houston, USA )
16 Dec 2014
Recurrence risk could be predicted by a multigene test in ductal carcinoma...
Prof Eileen Rakovitch - Sunnybrook Research Institute, Toronto, Canada
Recurrence risk could be predicted by a multigene test in ductal carcinoma breast cancer ( Prof Eileen Rakovitch - Sunnybrook Research Institute, Toronto, Canada )
16 Dec 2014
PD-1 inhibitor pembrolizumab shows promising clinical activity for triple...
Dr Rita Nanda - University of Chicago Medicine, Chicago, USA
PD-1 inhibitor pembrolizumab shows promising clinical activity for triple-negative breast cancer ( Dr Rita Nanda - University of Chicago Medicine, Chicago, USA )
12 Dec 2014
Adding ultrasound to routine mammography improves cancer detection in dense...
Dr Jean Weigert - Cancer Center of Central Connecticut, New Britain, USA
Adding ultrasound to routine mammography improves cancer detection in dense breasts ( Dr Jean Weigert - Cancer Center of Central Connecticut, New Britain, USA )
12 Dec 2014
CLL at ASH 2014: Expert discussion
Prof John Gribben and Prof Stephan Stilgenbauer
CLL at ASH 2014: Expert discussion ( Prof John Gribben and Prof Stephan Stilgenbauer )
12 Dec 2014
BOLERO-1 reports HER2-positive breast cancer latest PFS data
Prof Sara Hurvitz - University of California, Los Angeles, USA
BOLERO-1 reports HER2-positive breast cancer latest PFS data ( Prof Sara Hurvitz - University of California, Los Angeles, USA )
12 Dec 2014
Multigene test can predict risk of disease recurrence for women with ductal...
Prof Eileen Rakovitch - Sunnybrook Research Institute, Toronto, Canada
Multigene test can predict risk of disease recurrence for women with ductal carcinoma in situ ( Prof Eileen Rakovitch - Sunnybrook Research Institute, Toronto, Canada )
12 Dec 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation